Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT

Abstract

A growing body of evidence indicates that genetic factors are involved in an increased risk of infection. We investigated whether mannose-binding lectin (MBL) gene polymorphisms that cause low levels of MBL are associated with the occurrence of major infections in patients, mainly bearing hematological malignancies, after high-dose chemotherapy (HDT) rescued by autologous peripheral blood stem cell transplantation (auto-PBSCT). A retrospective evaluation of 113 patients treated with HDT and auto-PBSCT revealed that the low-producing genotypes, B/B and B/LXA, were associated with major bacterial infection (P=0.0016, OR 7.9). We next performed a nation-wide large-scale study to assess the allele frequency of the MBL coding mutation in a total of 2623 healthy individuals in Japan. The frequency of allele B was estimated to be 0.2, almost the same in seven different areas of Japan. This common occurrence suggests that MBL deficiency may play an important role in the clinical settings of immunosuppression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Turner MW . Mannose-binding lectin (MBL): the pluripotent molecule of the innate immune system. Immunol Today 1996; 17: 532–540.

    Article  CAS  Google Scholar 

  2. Matsushita M . The lectin pathway of the complement system. Microbiol Immunol 1996; 40: 887–893.

    Article  CAS  Google Scholar 

  3. Ghiran I, Barbashov SF, Klickstein LB, Tas SW, Jensenius JC, Nicholson-Weller A . Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med 2000; 192: 1797–1807.

    Article  CAS  Google Scholar 

  4. Turner MW . Mannose-binding lectin (MBL) in health and disease. Immunobiology 1998; 199: 327–339.

    Article  CAS  Google Scholar 

  5. Madson HO, Garred P, Thiel S et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995; 155: 3013–3020.

    Google Scholar 

  6. Aittoniemi J, Miettinen A, Laippala P et al. Age-dependent variation in the serum concentration of mannan-binding protein. Acta Paediatr 1996; 85: 906–909.

    Article  CAS  Google Scholar 

  7. Holmskov U, Thiel S, Jensenius JC . Collectins and ficolins: humoral lectins of the innate immune defense. Ann Rev Immunol 2003; 21: 547–548.

    Article  CAS  Google Scholar 

  8. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW . Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 1989; II: 1236–1239.

    Article  Google Scholar 

  9. Summerfield JA, Sumiya M, Levin M, Turner MW . Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 1997; 314: 1229–1232.

    Article  CAS  Google Scholar 

  10. Garred P, Madsen HO, Halberg P et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 2145–2152.

    Article  CAS  Google Scholar 

  11. Garred P, Pressler T, Madsen MO et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 1999; 104: 431–437.

    Article  CAS  Google Scholar 

  12. Gabolde M, Guilloud-Bataille M, Feingold J, Besmond C . Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: cohort study. BMJ 1999: 1166–1167.

    Article  CAS  Google Scholar 

  13. Neth O, Hann I, Turner MW, Klein NJ . Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 2001; 358: 614–618.

    Article  CAS  Google Scholar 

  14. Peterslund NA, Koch C, Jensenius JC, Thiel S . Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001; 358: 637–638.

    Article  CAS  Google Scholar 

  15. Mullighan CG, Heatley S, Doherty K et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002; 99: 3524–3529.

    Article  CAS  Google Scholar 

  16. Rocha V, Franco RF, Porcher R et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002; 100: 3908–3918.

    Article  CAS  Google Scholar 

  17. Kilpatrick DC, McLintock LA, Allan EK et al. No strong relationship between mannan binding lectin or plasma ficolons and chemotherapy-related infections. Clin Exp Immunol 2003; 134: 279–284.

    Article  CAS  Google Scholar 

  18. Morita C, Horiuchi T, Tsukamoto H et al. Association of tumor necrosis factor receptor type II polymorphism 196R with systemic lupus erythematosus in the Japanese. Molecular and functional analysis. Arthritis Rheum 2001; 44: 2819–2827.

    Article  CAS  Google Scholar 

  19. Kilpatrick DC . Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta 2002; 1572: 401–413.

    Article  CAS  Google Scholar 

  20. Horiuchi T, Tsukamoto H, Morita C et al. Mannose-binding lectin (MBL) gene mutation is not a risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Japanese. Genes Immun 2000; 1: 464–466.

    Article  CAS  Google Scholar 

  21. Shi L, Takahashi K, Dundee J et al. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 2004; 199: 1379–1390.

    Article  CAS  Google Scholar 

  22. Harada M . Allogeneic peripheral blood stem cell transplantation as an alternative to allogeneic bone marrow transplantation. Intern Med 1998; 37: 1001–1002.

    Article  CAS  Google Scholar 

  23. Siena S, Bregni M, Brando B et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400–409.

    CAS  Google Scholar 

  24. To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplant, and allogeneic bone marrow transplant. Bone Marrow Transplant 1992; 9: 277–284.

    CAS  PubMed  Google Scholar 

  25. Fujii K, Aoyama M, Shinagawa K et al. Risk of neutropenic fever and early complication after autologous peripheral blood stem cell transplantation for malignant diseases. Int J Hematol 2002; 76: 186–191.

    Article  Google Scholar 

  26. Van Burik JA, Weisdorf DJ . Infections in recipients of blood and marrow transplantation. Hematol Oncol Clin N Am 1999; 13: 1065–1089.

    Article  CAS  Google Scholar 

  27. Bergmann OJ, Christiansen M, Laursen I et al. Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukemia during remission induction therapy. Eur J Haematol 2003; 70: 91–97.

    Article  Google Scholar 

  28. Sasaki T, Tahira T, Suzuki A et al. Precise estimation of allele frequencies of single-nucleotide polymorphisms by a quantitative SSCP analysis of pooled DNA. Am J Hum Genet 2001; 68: 214–218.

    Article  CAS  Google Scholar 

  29. Tsutsumi A, Sasaki K, Wakamiya N et al. Mannose-binding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome. Genes Immun 2001; 2: 99–104.

    Article  CAS  Google Scholar 

  30. Valdimarsson H, Vikingdottir T, Bang P et al. Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol 2004; 59: 97–102.

    Article  CAS  Google Scholar 

  31. Valdimarsson H, Stefansson M, Vikingdottir T et al. Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL deficient humans. Scand J Immunol 1998; 48: 116–123.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T Horiuchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horiuchi, T., Gondo, H., Miyagawa, H. et al. Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT. Genes Immun 6, 162–166 (2005). https://doi.org/10.1038/sj.gene.6364165

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gene.6364165

Keywords

This article is cited by

Search

Quick links